Interesting article on intra-arterial infusion chemotherapy safety and outcomes for advanced lung cancer as an alternative therapy in candidates, who are not ideal for traditional therapies. 47.5% of patients showed response to therapy measured by RECIST criteria with median time to tumor progression of 5 months with minimal side effects.
http://www.jvir.org/article/S1051-0443(13)01089-0/fulltext
I am curious to know if there are a lot on institutions performing arterial directed therapies for other non-liver tumors, not just lung.
http://www.jvir.org/article/S1051-0443(13)01089-0/fulltext
I am curious to know if there are a lot on institutions performing arterial directed therapies for other non-liver tumors, not just lung.